Gastric cancer:: Helicobacter pylori, serum vitamin C, and other risk factors

被引:204
|
作者
You, WC
Zhang, L
Gail, MH
Chang, YS
Liu, WD
Ma, JL
Li, JY
Jin, ML
Hu, YR
Yang, CS
Blaser, MJ
Correa, P
Blot, WJ
Fraumeni, JF
Xu, GW
机构
[1] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[2] Beijing Med Univ, Beijing Inst Canc Res, Beijing 100083, Peoples R China
[3] Beijing Med Univ, Sch Oncol, Beijing 100083, Peoples R China
[4] Publ Hlth Bur, Shandong, Peoples R China
[5] Westat, Rockville, MD USA
[6] Rutgers State Univ, Piscataway, NJ USA
[7] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[8] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
[9] Louisiana State Univ, Med Ctr, New Orleans, LA USA
[10] Int Epidemiol Inst, Rockville, MD USA
关键词
D O I
10.1093/jnci/92.19.1607
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Gastric cancer is generally thought to arise through a series of gastric mucosal changes, but the determinants of the precancerous lesions are not well understood. To identify such determinants, me launched a follow-up study in 1989-1990 among 3433 adults in Linqu County, China, a region with very high rates of gastric cancer. Methods: Data on cigarette smoking, alcohol consumption, and other characteristics of the participants were obtained by interview in 1989-1990, when an initial endoscopy was taken. At study entry, antibodies to Helicobacter pylori were assayed in 2646 adults (77% of people screened), and levels of serum micronutrients were measured in approximately 450 adults. Follow-up endoscopic and histopathologic examinations were conducted in 1994. Antibodies to H. pylori, levels of serum micronutrients, and other baseline characteristics were compared between subjects whose condition showed progression to dysplasia or gastric cancer from study entry to 1994 and subjects with no change or with regression of their lesions over the same time frame. All P values are two-sided. Results: The presence of H, pylori at baseline was associated with an increased risk of progression to dysplasia or gastric cancer (odds ratio [OR] = 1.8; 95% confidence interval [CI] = 1.2-2.6). The risk of progression to dysplasia or gastric cancer also was moderately increased with the number of years of cigarette smoking. In contrast, the risk of progression was decreased by 80% (OR = 0.2; 95% CI = 0.1-0.7) among subjects with baseline ascorbic acid levels in the highest tertile compared with those in Conclusions: H. pylori infection, cigarette smoking, and low levels of dietary vitamin C may contribute to the progression of precancerous lesions to gastric cancer in this high-risk population.
引用
收藏
页码:1607 / 1612
页数:6
相关论文
共 50 条
  • [41] Gastric mucosal vitamin C levels in Helicobacter pylori infection.
    Phull, PS
    Price, AB
    White, K
    Schorah, CJ
    Jacyna, MR
    GASTROENTEROLOGY, 1996, 110 (04) : A229 - A229
  • [42] Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis
    Gomez-Ramirez, Uriel
    Valencia-Mayoral, Pedro
    Mendoza-Elizalde, Sandra
    Murillo-Eliosa, Juan Rafael
    Solorzano Santos, Fortino
    Contreras-Rodriguez, Araceli
    Zuniga, Gerardo
    Aguilar-Rodea, Pamela
    Jimenez-Rojas, Veronica Leticia
    Vigueras Galindo, Juan Carlos
    Salazar-Garcia, Marcela
    Velazquez-Guadarrama, Norma
    PATHOGENS, 2021, 10 (09):
  • [43] The effect of Helicobacter pylori infection on vitamin C concentration in gastric juice
    Jarosz, M
    Dzieniszewski, J
    DabrowskaUfniarz, E
    Wartanowicz, M
    Ziemlanski, S
    GUT, 1997, 41 : A110 - A110
  • [44] Risk Stratification for Gastric Cancer Using Serum Pepsinogen and Helicobacter pylori Serology in a Chinese Population
    Benjamin, Yip C.
    Feng, Zhu
    Ho, Khek-Yu
    Christopher, Khor
    Lim, Lee Guan
    So, Jimmy B.
    Chung-King, Chia
    Lim, Wee Chian
    Rao, Jaideepraj
    Teh, Ming
    Srivastava, Supriya
    Sethi, Sunil
    Ling, Khoon-Lin
    Ooi, Choon Jin
    Ang, Tiing Leong
    Fock, Kwong Ming
    Wong, Andrew S.
    Yeoh, Khay Guan
    GASTROENTEROLOGY, 2012, 142 (05) : S631 - S631
  • [45] How does vitamin C administration decrease the risk of gastric cancer in the Helicobacter pylori-positive patients with atrophic gastritis?
    Tari, A
    Kitadai, Y
    Sumii, M
    Tani, H
    Tanaka, S
    Chayama, K
    HELICOBACTER, 2005, 10 (05) : 535 - 536
  • [46] Serum anti-Helicobacter pylori antibodies and the risk of chronic atrophic gastritis and gastric cancer
    Tsai, CJ
    Zhang, ZF
    Yu, GP
    Kurtz, RC
    GASTROENTEROLOGY, 2000, 118 (04) : A760 - A760
  • [47] Helicobacter Pylori and Gastric Cancer
    Pandey, Renu
    Misra, Vatsala
    Misra, S. P.
    Dwivedi, Manisha
    Kumar, Ajay
    Tiwari, Balesh Kumar
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (03) : 583 - 588
  • [48] Helicobacter pylori and gastric cancer
    Walker, ARP
    AMERICAN JOURNAL OF MEDICINE, 1999, 107 (06): : 646 - 647
  • [49] Helicobacter pylori and gastric cancer
    Krejs, GJ
    ACTA MEDICA AUSTRIACA, 2000, 27 (04) : 129 - 130
  • [50] Helicobacter pylori and gastric cancer
    Reed, PI
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1996, 5 : 49 - 55